
AstraZeneca to buy biotech firm TeneoTwo for up to $1.27 billion
(Reuters) -AstraZeneca agreed to acquire biotechnology firm TeneoTwo Inc in a deal worth up to $1.27...
5th July, 2022

(Reuters) -AstraZeneca agreed to acquire biotechnology firm TeneoTwo Inc in a deal worth up to $1.27...
5th July, 2022

By Mohammad Yunus Yawar KABUL (Reuters) – Afghanistan lacks the medical supplies to treat those inju...
24th June, 2022

(Fixes typographical error in media identifier) By Natalie Grover PARIS/LONDON (Reuters) -Late-stage...
24th June, 2022

By Alistair Smout LONDON (Reuters) -U.S. biotech firm Moderna will build a new research and manufact...
22nd June, 2022

By Jennifer Rigby and Francesco Guarascio LONDON (Reuters) – Leaders of the global scheme aiming to...
22nd June, 2022

By Natalie Grover LONDON (Reuters) -British authorities are recommending gay and bisexual men at hig...
21st June, 2022

Consortium that supports the design and adoption of blockchain-enabled healthcare solutions to deplo...
21st June, 2022

PARIS (Reuters) -U.S. healthcare giant Pfizer has agreed to invest 90.5 million euros ($95.24 millio...
20th June, 2022

By Natalie Grover and Jennifer Rigby LONDON (Reuters) -The World Health Organisation is looking into...
15th June, 2022

BRUSSELS (Reuters) -The European Union signed on Tuesday an agreement with Bavarian Nordic for the s...
14th June, 2022

By Ludwig Burger FRANKFURT (Reuters) -Two new subvariants of Omicron, BA.4 and BA.5, are spreading m...
13th June, 2022

By Manas Mishra (Reuters) -Moderna Inc said on Wednesday a new version of its coronavirus vaccine pr...
8th June, 2022